Heart Failure 2012
نویسندگان
چکیده
منابع مشابه
Heart Failure 2012
© 2012 Gregory Giamouzis et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License ( http://creativecommons.org/licenses/by/3.0/), which permits making multiple copies, distribution, public display, and publicly performance, distribution of derivative works, provided the original work is properly cited. This license requires credi...
متن کاملThe 2012 ESC Guidelines on Heart Failure.
The latest Guidelines feature new evidence on diagnosis, drugs, and devices The ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 were developed by the European Society of Cardiology (ESC) in collaboration with the Heart Failure Association (HFA) of the ESC. They were presented for the first time in May 2012 at the Heart Failure Congress in Belgrade, Serbia,...
متن کاملThe Year in Cardiology 2012: heart failure.
In 2012 there were a number of important advances within the clinical arena of heart failure. Recent new evidence was dissected, analysed, synthesized, and incorporated into the new European Society of Cardiology Heart Failure Guideline 2012 which will facilitate the translation of clinical research in heart failure into improved patient care. In addition there were new therapeutic treatment tr...
متن کاملHeart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline.
BACKGROUND The South African Heart Association (SA Heart) is an affiliate of the European Society of Cardiology (ESC). SA Heart endorses ESC treatment guidelines with modification to suit local circumstances. The Heart Failure Society of South Africa (HeFSSA) is a special interest group of SA Heart. This guideline has been compiled on behalf of the HeFSSA and is based on the ESC guidelines for ...
متن کاملEmerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiology Research and Practice
سال: 2012
ISSN: 2090-8016,2090-0597
DOI: 10.1155/2012/126324